停用实时CGM对基础胰岛素治疗2型糖尿病成人血糖控制的影响
多中心试验纳入基础胰岛素治疗(无餐时胰岛素)的2型糖尿病成人,先随机接受实时CGM或BGM 8个月,随后6个月BGM组继续BGM(n=57),CGM组再随机分为继续CGM(n=53)或停用CGM恢复BGM(n=53)。停用CGM组TIR从8个月时62%降至14个月时50%(平均变化-12%,95%CI -21%至-3%,P=0.01),继续CGM组TIR变化较小(平均变化1%,95%CI -11%至12%,P=0.89);14个月时两组调整后TIR差异为-6%(95%CI -16%至4%,P=0.20)。
要点
- 停用CGM后TIR较继续使用CGM时下降约12%,丢失初始TIR增益的一半左右。
- 继续使用CGM组TIR从8个月到14个月基本维持,组间差异未达统计学显著。
- 对基础胰岛素治疗的2型糖尿病成人,停用CGM可能削弱已获得的血糖改善。
核心结论
- 在已使用实时CGM 8个月的基础胰岛素治疗2型糖尿病成人中,停用CGM导致初始TIR增益丢失约一半。
研究设计与样本
- 多中心试验:先随机接受实时CGM或BGM 8个月,随后6个月BGM组继续BGM(n=57),CGM组再随机分为继续CGM(n=53)或停用CGM恢复BGM(n=53)。
主要发现
- 停用CGM组TIR从8个月时62%降至14个月时50%,平均变化-12%(95%CI -21%至-3%,P=0.01)。
- 继续CGM组TIR从8个月时56%至14个月时57%,平均变化1%(95%CI -11%至12%,P=0.89)。
- 14个月时两组调整后平均TIR差异为-6%(95%CI -16%至4%,P=0.20)。
临床怎么用
- 对基础胰岛素治疗的2型糖尿病成人,停用CGM需评估TIR下降风险,可能需加强BGM或考虑继续CGM。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin. RESEARCH DESIGN AND METHODS: This multicenter trial had an initial randomization to either real-time CGM or blood glucose monitoring (BGM) for 8 months followed by 6 months in which the BGM group continued to use BGM (n = 57) and the CGM group was randomly reassigned either to continue CGM (n = 53) or discontinue CGM with resumption of BGM for glucose monitoring (n = 53). RESULTS: In the group that discontinued CGM, mean time in range (TIR) 70-180 mg/dL, which improved from 38% before initiating CGM to 62% after 8 months of CGM, decreased after discontinuing CGM to 50% at 14 months (mean change from 8 to 14 months -12% [95% CI -21% to -3%], P = 0.01). In the group that continued CGM use, little change was found in TIR from 8 to 14 months (baseline 44%, 8 months 56%, 14 months 57%, mean change from 8 to 14 months 1% [95% CI -11% to 12%], P = 0.89). Comparing the two groups at 14 months, the adjusted treatment group difference in mean TIR was -6% (95% CI -16% to 4%, P = 0.20). CONCLUSIONS: In adults with type 2 diabetes treated with basal insulin who had been using real-time CGM for 8 months, discontinuing CGM resulted in a loss of about one-half of the initial gain in TIR that had been achieved during CGM use.
引用
- Aleppo G, Beck RW, Bailey R, et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care. 2021. PMID: 34588210. doi:10.2337/dc21-1304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。